SOURCE: Industrial Info Resources

September 06, 2007 09:09 ET

Generic Drugmaker Watson Pharma Expands Asian Operations as it Consolidates in U.S., an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - September 6, 2007) - Researched by Industrial Info Resources (Sugar Land, Texas) -- The Food and Drug Administration (FDA) has granted U.S.-based drug company Watson Pharmaceuticals Incorporated (NYSE:WPI) its first product approval in India. The approval is expected to be just one of many the company anticipates seeking for the production of additional solid-dosage drug products at its generics plant in Goa, which the company purchased from Doctor Reddy's Laboratories in 2005. While exporting the majority of its Goa products to the U.S., Watson is shedding sites domestically.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=118908, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) provides marketing communication services ranging from industrial database solutions to market forecasting, custom analytics, and specialty promotions that support high-level image campaigns. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147